Drugs / multipotent stromal cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02893306 | Mar 2012 → Mar 2017 | type 1 diabetes mellitus | Universidad del Desarrollo | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | multipotent stromal cell | “multipotent stromal cell also referred as to mesenchymal stem cells (MSCs)” NCT02893306 ↗ |
| Known as | MSCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02893306 ↗ |
| Modality | Cell therapy | “allogeneic ex vivo expanded mesenchymal stem cells” NCT02893306 ↗ |
| Route | Intravenous | “via: intravenous” NCT02893306 ↗ |